Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Clinical implications and research priorities When considering the use of GLP-1 RAs in patients with IBD and comorbid obesity or diabetes, practising clinicians need to recognise the need for shared decision-making that weighs metabolic benefits against limited prospective efficacy data and evolving safety data
Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment
* Promote smoother, softer, healthier-looking skin
Insulin in the brain: There and back again
Retatrutide is a weight loss drug candidate that demonstrates impressive phase 2 results
In the research world, it is regularly associated with tendon, ligament, soft tissue, gut lining, and inflammation-related healing pathways
US$ 21.86
US$ 22.70
US$ 24.22
US$ 21.00
US$ 29.29
US$ 23.43
